Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/17/12 → 1/31/18 |
Funding
- Lexicon Pharmaceuticals Incorporated: $228,279.00
12-GI-85-LP (LX1606) Evaluate LX1606 in Patients with Carcinoid Syndrome Refractory to Somatostatin Analog (SSA) Therapy
- Anthony, Lowell (PI)
- DeSimone, Philip (Former CoI)
- Jones, Dennie (Former CoI)